Loading…
PHG
Koninklijke Philips NV
NYSE· Healthcare· Medical Devices
$26.72-0.74%
Key metrics
- Market cap
- $26.12B
- P/E
- 20.1x
- Forward P/E
- 14.0x
- P/B
- 2.0x
- Dividend yield
- 3.78%
- EPS
- $1.33
- ROE
- 10.15%
- Profit margin
- 6.31%
- Revenue growth
- +0.50%
- Beta
- 0.91
- 52-week high
- $33.44
- 52-week low
- $23.85
History
How the company evolved, year by year. Revenue and debt come from the annual statements; dividends from the payments themselves, which reach further back.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
About the company
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
- 63,670
- Amsterdam, Netherlands
Company description provided by Yahoo Finance.